Modified FOLFOX plus/minus Nivolumab and Ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction - The randomized phase 2 MOONLIGHT trial.<br />

Bösartige Erkrankungen des oberen Verdauungstraktes (Oesophagus, Magen, gastrooesophagealer Übergang)

Karzinom des gastrooesophagealen Übergangs

Magenkarzinom

CTLA-4 (cytotoxic T-lymphocyte-associated Protein 4)

HER2/neu

PD-1 (Programmed cell death protein 1)

Phase II

MOONLIGHT

Erstlinie

Advanced

Metastatic

Comprehensive Cancer Center Mainfranken

Studien des CCC Mainfranken